Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACVRL1 | P37023 | 6/20 | 0.45 |
| ▸ | TNK2 | Q07912 | 5/20 | 0.43 |
| ▸ | CSNK2A2 | P19784 | 5/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 5/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | RICTOR | Q6R327 | 1/20 | 0.41 |
| ▸ | RPTOR | Q8N122 | 1/20 | 0.41 |
| ▸ | MAPKAP1 | Q9BPZ7 | 1/20 | 0.41 |
| ▸ | MLST8 | Q9BVC4 | 1/20 | 0.41 |
| ▸ | AXL | P30530 | 2/20 | 0.41 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.41 |
| ▸ | MERTK | Q12866 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27315088 | 0.85 | CSNK2A2 (0.43) | ACVRL1TNK2CSNK2A2CSNK2A1PIK3CD | |
| SCHEMBL29927041 | 0.80 | RIPK1 (0.47) | TNK2CSNK2A2CSNK2A1 | |
| SCHEMBL27315078 | 0.79 | ACVRL1 (0.47) | ACVRL1TNK2PIK3CD | |
| SCHEMBL27315079 | 0.78 | ACVRL1 (0.46) | ACVRL1TNK2PIK3CDMTORRICTOR | |
| SCHEMBL10105828 | 0.77 | ACVRL1 (0.39) | ACVRL1TNK2CSNK2A2CSNK2A1PIK3CD | |
| SCHEMBL27315264 | 0.75 | AXL (0.48) | CSNK2A2CSNK2A1AXLTYRO3MERTK | |
| SCHEMBL27315261 | 0.75 | RET (0.47) | CSNK2A2CSNK2A1AXLTYRO3MERTK | |
| SCHEMBL14651915 | 0.75 | NTRK1 (0.38) | ACVRL1TNK2CSNK2A2CSNK2A1PIK3CD | |
| SCHEMBL12283438 | 0.75 | NTRK1 (0.38) | ACVRL1TNK2CSNK2A2CSNK2A1PIK3CD | |
| SCHEMBL27315239 | 0.74 | RET (0.51) | AXLTYRO3MERTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611900-A1 | RET-LDD PROTEIN INHIBITORS | Bristol-Myers Squibb Company (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097980-A1 | RET-LDD PROTEIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024097980-A1 | RET-LDD PROTEIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-05-10 | — | — | WO | disclosed |